Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: 613 who wrote (1548)	2/19/2003 9:27:55 AM
From: Fred Levine	Read Replies (1) \| Respond to of 1605

From the last quarterly report: . Operating results were further impacted by a $491,000 charge to the Company's provision for doubtful accounts, as compared to $99,000 during the second quarter of fiscal 2002. This charge resulted primarily from reserves applied against certain domestic and international accounts for which extended credit terms were previously offered. This charge was offset by a bad debt recovery of $479,000, which represents the net book value of EECP equipment repossessed when a major customer ceased operations. fred